You are viewing a free preview of this lesson.
Subscribe to unlock all 10 lessons in this course and every other course on LearningBro.
Spec mapping (AQA 7037): Paper 2, §3.2.4 Population and the Environment — the relationship between the physical environment and human health; the global pattern of health, mortality and morbidity; the epidemiological transition; the link between development and health; the environmental, social and economic determinants of health; communicable and non-communicable diseases. This lesson extends the demographic work of Lessons 1–2 (mortality and life expectancy are health outcomes) into the geography of health and disease, and sets up the disease and global-health-governance lesson that follows. It links synoptically to §3.2.1 Global Systems and Global Governance (health is shaped by global flows, inequality and institutions such as the WHO) and to §3.1.1 Water and Carbon Cycles (climate and water quality are primary environmental determinants of health, and climate change is altering disease distributions). Assessment objectives: AO1 — knowledge of health measures, Omran's epidemiological transition, and the environmental, social and economic determinants of health; AO2 — application to real contexts (UK air pollution, sub-Saharan malaria, the Marmot social gradient); AO3 — interpretation and evaluation of health and disease data to reach a substantiated judgement.
This lesson examines global patterns of health and disease, Omran's epidemiological transition model (1971), the distinction between communicable and non-communicable diseases, and the environmental, social and economic determinants of health. Understanding why health outcomes vary so sharply between and within places is central to the Population and the Environment option.
Before analysing patterns, it is important to understand how health is measured at population level:
| Indicator | Definition | Significance |
|---|---|---|
| Life expectancy at birth | Average years a newborn is expected to live | Overall health and development indicator |
| Infant Mortality Rate (IMR) | Deaths under age 1 per 1,000 live births | Sensitive indicator of healthcare quality, nutrition, and sanitation |
| Under-5 Mortality Rate | Deaths under age 5 per 1,000 live births | Broader child health measure |
| Maternal Mortality Ratio (MMR) | Maternal deaths per 100,000 live births | Quality of reproductive healthcare |
| DALYs (Disability-Adjusted Life Years) | Years of healthy life lost to disease or disability | Captures burden of non-fatal conditions |
| Morbidity rate | Prevalence or incidence of disease | Measures illness, not just death |
| Country/Region | Life Expectancy (2023) | IMR (per 1,000) | Key Health Challenges |
|---|---|---|---|
| Japan | 84.8 years | 1.8 | Ageing population, mental health |
| UK | 80.7 years | 3.7 | Obesity, NHS pressures, health inequalities |
| USA | 77.5 years | 5.4 | Obesity, opioid crisis, healthcare inequality |
| India | 70.8 years | 27.4 | Communicable diseases, malnutrition, air pollution |
| Nigeria | 53.9 years | 72.2 | Malaria, maternal mortality, weak healthcare infrastructure |
| Sierra Leone | 54.7 years | 78.5 | Poverty, Ebola aftermath, limited healthcare |
Exam Tip: Health inequalities exist not just between countries but within them. In the UK, life expectancy varies by up to 10 years between the most and least deprived areas (e.g., Blackpool vs. Hart district in Hampshire). Always consider intra-national health inequalities for a more nuanced analysis.
These indicators are not interchangeable, and choosing the right one is itself an AO3 skill. Life expectancy is the broadest summary but is dominated by deaths in infancy (a few infant deaths drag the average down sharply) and tells you nothing about quality of life. The infant mortality rate is the most sensitive indicator of a population's underlying conditions — it responds quickly to changes in nutrition, clean water, sanitation and basic healthcare — which is why it varies so dramatically between rich and poor countries and is often used as a single proxy for development. DALYs add the crucial dimension of morbidity (illness and disability, not just death), capturing the growing burden of conditions like depression, diabetes and chronic pain that disable without killing. And the maternal mortality ratio is a searching test of whether a health system functions, because safe childbirth requires skilled attendants, emergency surgery and blood supplies. A sophisticated answer selects the indicator that best fits the question rather than defaulting to life expectancy alone.
Abdel Omran (1971) proposed the epidemiological transition model, which describes how the pattern of disease changes as a country develops economically and undergoes the demographic transition.
graph LR
S1["Stage 1: Age of<br/>Pestilence & Famine<br/>Infectious disease,<br/>famine, high mortality"] --> S2["Stage 2: Age of<br/>Receding Pandemics<br/>Improved sanitation,<br/>medicine; mortality falls"]
S2 --> S3["Stage 3: Age of<br/>Degenerative & Man-Made<br/>Diseases<br/>Heart disease, cancer,<br/>stroke dominate"]
S3 --> S4["Stage 4: Age of<br/>Delayed Degenerative<br/>Diseases<br/>Medical advances extend<br/>life with chronic conditions"]
| Stage | Name | Dominant Diseases | Life Expectancy | Example |
|---|---|---|---|---|
| 1 | Age of Pestilence and Famine | Infectious diseases: plague, cholera, smallpox, tuberculosis; famine | 20–40 years | Pre-industrial societies; no modern examples |
| 2 | Age of Receding Pandemics | Infectious diseases decline as sanitation, nutrition, and medicine improve | 30–50 years | Parts of sub-Saharan Africa (transitioning) |
| 3 | Age of Degenerative and Man-Made Diseases | Non-communicable diseases: cardiovascular disease, cancer, stroke, diabetes | 50–75 years | UK (mid-20th century), emerging economies |
| 4 | Age of Delayed Degenerative Diseases | Same diseases as Stage 3, but onset delayed by medical advances (statins, chemotherapy, screening) | 75+ years | UK, Japan, most HICs today |
Omran's model parallels the DTM and is best understood alongside it: as a society industrialises (DTM Stage 2 onwards), the same improvements that cut the death rate — sanitation, clean water, nutrition, vaccination, antibiotics — also shift the causes of death away from infection. The diseases that remain are the degenerative conditions of long life (heart disease, cancer, stroke) plus "man-made" diseases of modern lifestyle and environment (obesity, smoking-related cancers, pollution). Omran identified several possible paths through the transition: a "classical/Western" model (slow, as in Europe), an "accelerated" model (faster, as in Japan), and a "delayed/contemporary" model for developing countries where the transition is incomplete and the change is driven heavily by imported medical technology rather than internal development — which is why many LICs face a mixed disease burden.
Some scholars have proposed a fifth stage characterised by the re-emergence of infectious diseases (e.g., antibiotic-resistant bacteria, novel pandemics like COVID-19) alongside persistent non-communicable diseases. This concept, sometimes called the Age of Re-emerging Infectious Diseases, reflects:
The plausibility of Stage 5 is a strong evaluative point: it suggests Omran's optimistic, one-directional model under-estimated the resilience and adaptability of pathogens and the new risks created by globalisation and environmental change.
| Feature | Communicable Diseases (CDs) | Non-Communicable Diseases (NCDs) |
|---|---|---|
| Definition | Diseases caused by pathogens (bacteria, viruses, parasites) that can be transmitted between people or from animals | Diseases not caused by infection and not transmissible between people |
| Examples | Malaria, tuberculosis, HIV/AIDS, cholera, COVID-19 | Cardiovascular disease, cancer, diabetes, COPD, mental illness |
| Transmission | Direct contact, airborne, waterborne, vector-borne | Not transmitted; caused by genetics, lifestyle, environment |
| Geographic pattern | More prevalent in LICs (due to poverty, poor sanitation, limited healthcare) | More prevalent in HICs (due to ageing, diet, sedentary lifestyle) but increasing rapidly in LICs/MICs |
| Prevention | Vaccination, sanitation, mosquito control, hygiene education | Lifestyle changes (diet, exercise, smoking cessation), screening |
Key Definition: A vector-borne disease is one transmitted by an organism (vector), typically an insect. Malaria is transmitted by Anopheles mosquitoes; dengue by Aedes mosquitoes; Lyme disease by ticks.
The communicable/non-communicable distinction maps directly onto the development gradient and the epidemiological transition. In the poorest countries (earlier transition stages), the disease burden is dominated by communicable diseases linked to poverty, unsafe water and weak healthcare — a burden that is, in principle, preventable through development. In rich countries (later stages), the burden has shifted to non-communicable diseases of ageing and lifestyle. The complication, increasingly important, is that middle-income countries now face both at once — the unfinished business of infection plus the rising tide of chronic disease from the nutrition transition and ageing — the "double burden" that strains their developing health systems. This is why the simple "infectious = poor, chronic = rich" picture is breaking down, and why the geography of disease is becoming more complex rather than less.
The relationship between environment and health operates through multiple pathways:
Key Definition: The social determinants of health are the conditions in which people are born, grow, live, work, and age. Sir Michael Marmot's landmark research (the Marmot Review, 2010, updated 2020) demonstrated that health inequalities in England follow a "social gradient" — the lower the socio-economic position, the worse the health outcomes, in a continuous gradient (not just rich vs poor).
The link between development and health is strong but non-linear and two-way, which is essential for evaluation.
This last point is the key evaluative move: development enables good health, but how a society distributes income and invests in public health determines whether that potential is realised.
Southern Africa shows the development–health relationship working in reverse — a disease so severe it set back demographic and economic progress:
This case is invaluable because it shows that health and development are mutually dependent, that the epidemiological transition is not guaranteed to be one-directional, and that global action (the subject of the next lesson) can reverse a health catastrophe.
Subscribe to continue reading
Get full access to this lesson and all 10 lessons in this course.